Previous
Next
Welcome to collaborative research.
Where science, technology
and translation converge
Our formula to develop trailblazing drugs and advance health sciences is based on extreme collaboration between three hubs: ambitious scientific research, ever-evolving technological innovation and a constant translational effort of carrying our breakthroughs from bench to bedside.
Latest breakthroughs
Innovation in medicine is happening right now. Keep up with us.
Pinto D, Gonçalo R, Louro M, Silva MS, Hernandez G, Cordeiro TN, Cordeiro C, São-José C. On the occurrence and multimerization of two-polypeptide phage endolysins encoded in single genes. Microbiol Spectr. 2022; 10:e0103722. DOI: 10.1128/spectrum.01037-22.
- September 5, 2022
- Phage Biology Research and Infection Control
Gomes RFA, Ravasco JMJM, Andrade KHS, Coelho JAS, Moreira R, Oliveira R, Nogueira F, Afonso CAM. Tandem Thio-Michael Addition/Remote Lactone Activation of 5-Hydroxymethylfurfural-Derived δ-Lactone-Fused Cyclopentenones. ChemSusChem. 2022; e202102204. DOI: 10.1002/cssc.202102204.
- April 27, 2022
- Bioorganic Chemistry
Gouveia A, Pinto D, Veiga H, Antunes W, Pinho MG, São-José C. Synthetic antimicrobial peptides as enhancers of the bacteriolytic action of Staphylococcal phage endolysins. Sci Rep. 2022; 12:1245. DOI: 10.1038/s41598-022-05361-1.
- February 5, 2022
- Phage Biology Research and Infection Control
imed
September 22, 2022
Partners
iMed is a FCT funded research centre but we don't act alone. Every in-house member at imed advances our purpose but we also collaborate with some distinguished external partners.
ULisboa
Faculdade de Farmácia
FCT
República Portuguesa
Example Title
